Internal Medicine, Medical Oncology · Phoenix, AZ
NPI
1093008336
Since 2011
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
11209 N Tatum Blvd Ste B200
Phoenix, AZ, 85028
Phone (480) 530-4200
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
75,931 services
Medicare patients, 2024
355
Average age 75
Drug cost, 2024
$3.4M
1,467 prescriptions
Company payments, 2025
$2,087
From 39 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amber L Flaherty was code J0897 (injection, denosumab, 1 mg), 7,260 times for 27 patients. In total Amber L Flaherty billed 75,931 services in 102 codes, and Medicare paid $1.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-09-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 7,260 | 27 | $20.45 | $148K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 3,000 | 11 | $0.11 | $318 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,098 | 29 | $0.09 | $99.13 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 468 | 20 | $0.08 | $35.14 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 400 | 14 | $0.68 | $272 |
| 99214 Office E&M - Established | Office | 393 | 169 | $94.71 | $37K |
| 96375 Injection Administration | Office | 309 | 40 | $11.70 | $3,615 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 276 | 42 | $136.50 | $38K |
| 99213 Office E&M - Established | Office | 238 | 163 | $63.98 | $15K |
| 99215 Office E&M - Established | Office | 171 | 77 | $138.05 | $24K |
| 96372 Injection Administration | Office | 170 | 49 | $10.79 | $1,834 |
| 96413 Chemotherapy Administration | Office | 160 | 43 | $98.29 | $16K |
| 96402 Chemotherapy Administration | Office | 106 | 45 | $26.68 | $2,828 |
| 96415 Chemotherapy Administration | Office | 86 | 14 | $21.11 | $1,815 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 72 | 23 | $0.65 | $46.78 |
By year: 2022 $1.2M for 64,840 services; 2023 $1.6M for 91,619 services; 2024 $1.3M for 75,931 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 17 | 14 | $8.65 | $147 |
Medicare prescription drug claims, 2024
In 2024, the drug Amber L Flaherty prescribed most often to Medicare patients was Oxycodone Hcl, with 97 prescriptions and refills. In total Amber L Flaherty wrote 1,467 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 97 | 97 | 14 | $3,179 |
| Abiraterone Acetate Generic | 95 | 95 | 17 | $109K |
| Eliquis Apixaban | 88 | 174 | 25 | $99K |
| Lorazepam Generic | 62 | 63 | 20 | $381 |
| Xtandi Enzalutamide | 57 | 57 | 11 | $344K |
| Prednisone Generic | 45 | 107 | 22 | $507 |
| Anastrozole Generic | 41 | 120 | 15 | $987 |
| Hydroxyurea Generic | 38 | 101 | 11 | $1,380 |
| Ondansetron Hcl Generic | 38 | 38 | 13 | $384 |
| Tramadol Hcl Generic | 37 | 37 | 17 | $478 |
| Ondansetron Odt Ondansetron | 34 | 36 | 14 | $574 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 34 | 34 | 11 | $1,425 |
| Xtampza Er Oxycodone Myristate | 27 | 27 | Under 11 | $18K |
| Imbruvica Ibrutinib | 27 | 27 | Under 11 | $435K |
| Xarelto Rivaroxaban | 26 | 76 | Under 11 | $42K |
Brand drugs: 446 claims; generic drugs: 1,021 claims; opioid claims: 266.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amber L Flaherty $2,087 ($2,087 in general payments such as food, travel and fees) from 39 companies. The largest payer was Daiichi Sankyo Inc. with $271.
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. 4568.T | 18 | $271 |
| Merck Sharp & Dohme LLC MRK | 5 | $147 |
| Pfizer Inc. PFE | 7 | $146 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $116 |
| Abbvie Inc. ABBV | 5 | $105 |
| Celgene Corporation BMY | 5 | $100 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $93.07 |
| Sobi, Inc SOBI.ST | 3 | $56.82 |
| Stemline Therapeutics Inc. | 2 | $55.97 |
| Genzyme Corporation SNY | 2 | $55.33 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.